Reported Earlier, Shuttle Pharmaceuticals Prices $4.5M Public Offering Of 2,950,820 At-The-Market Under Nasdaq Rules
Portfolio Pulse from Benzinga Newsdesk
Shuttle Pharmaceuticals has announced a $4.5 million public offering of 2,950,820 shares at-the-market under Nasdaq rules.
October 30, 2024 | 7:52 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Shuttle Pharmaceuticals has priced a $4.5 million public offering of 2,950,820 shares at-the-market under Nasdaq rules, which may lead to stock price fluctuations.
The public offering increases the number of shares available in the market, which can lead to a dilution of existing shares and potentially lower the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100